RT @jitcancer: #JITC Commentary: Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in precl…
304 followers
8,160 followers
#JITC Commentary: Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in preclinical models and the need to incorporate human modifying factors https://t.co/6DLbYk54T7 https://t.co/Pt9tI1uhOS
440 followers
RT @jitcancer: New #JITC Commentary: Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in p…
1,738 followers
RT @jitcancer: New #JITC Commentary: Moving forward to address key unanswered questions on targeting PD-1/PD-L1 in cancer: limitations in p…